Highlights
- 1The Journal of thoracic and cardiovascular surgery · 2022
Publications
65 publications
Clinical research
1 study
Completed & closed trials (1)
- PINCT05120349A Phase III, Double-blind, Randomised, Placebo-Controlled, International Study to Assess the Efficacy and Safety of Adjuvant Osimertinib Versus Placebo in Participants With EGFR Mutation-positive Stage IA2-IA3 Non-small Cell Lung Cancer, Following Complete Tumour ResectionPHASE3 · AstraZeneca Pharmaceuticals LP · CLOSED TO ACCRUAL (as of 2024)Non-Small Cell Lung Cancer
External relationships
Other
AstraZeneca Pharmaceuticals LP · Laborie Medical Technologies Corp